An Herbal Medicine, Yukgunja-Tang is more Effective in a Type of Functional Dyspepsia Categorized by Facial Shape Diagnosis: A Placebo-Controlled, Double-Blind, Randomized Trial

Table 3

Characteristics of the patients and baseline TDS scale, SDS scale, VAS for overall dyspeptic symptoms, NDI-K, FD-QoL questionnaire, and SQDQ.

Variables/Group	Gallbladder body	Bladder body	Placebo	P value
	(n = 32)	(n = 32)	(n = 32)
Mean age	47.16 (11.83)	47.22 (11.60)	45.28 (12.27)	0.761
Mean weight (kg)	56.56 (7.93)	60.01 (9.39)	57.60 (10.28)	0.313
Mean BMI (kg/m^2)	21.98 (2.85)	23.28 (3.09)	22.21 (2.74)	0.165
Male (%)	15.6	15.6	15.6	1.000
TDS scale	8.81 (3.60)	8.41 (3.09)	8.66 (4.35)	0.907
SDS scale	15.28 (5.76)	14.78 (6.63)	14.72 (6.61)	0.927
VAS for overall dyspeptic symptoms	68.03 (12.09)	60.75 (18.24)	63.16 (9.06)	0.101
NDI-K	52.28 (27.74)	49.63 (30.48)	51.41 (30.56)	0.935
FD-QoL questionnaire	28.44 (20.98)	19.28 (11.77)	25.09 (17.80)	0.106
SQDQ	47.97 (19.22)	39.21 (15.50)	47.16 (16.15)	0.081

TDS: Total Dyspepsia Symptom; SDS: Single Dyspepsia Symptom; VAS: Visual Analogue Scale; NDI-K: Nepean Dyspepsia Index-Korean Version; FD-QoL: Functional Dyspepsia-Related Quality of Life; SQDQ: Spleen Qi Deficiency Questionnaire; BMI: Body Mass Index.
Both gallbladder and bladder body groups are treatment groups.
Baseline values were analyzed by Pearson’s chi-squared test for categorical variables and one way-ANOVA for continuous variables.
Continuous variables are presented as mean (standard deviation).
P value < 0.05 is regarded as statistically significant.